RS

Ravi Shekhar

Active Director Director DIN 09791553
DIN 09791553 First appointment Nov 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2022
Shareholding value Locked Premium profile

About Ravi Shekhar

Ravi Shekhar has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Rewansh Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09791553
Primary Designation Director
First Appointment 15 Nov 2022
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Rewansh Pharma Private Limited U24230UP2022PTC173398
Director 15 Nov 2022 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rewansh Pharma Private Limited
Premium access

Shareholding and investment profile for Ravi Shekhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Shekhar

Ravi Shekhar has 3 years in corporate governance. Holds Director role. Currently with 1 company, including Rewansh Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ravi Shekhar is associated with 1 company as Director.

Ravi Shekhar has expertise in General Business.

Ravi Shekhar has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available